Bristol-Myers to Acquire Celgene in Deal Worth $74 Billion

Together, the merged companies would have nine pharmaceutical products with more than $1 billion in annual sales each. The deal is expected to be completed in the third quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *